JCR Pharmaceuticals Announces That Acumen Pharmaceuticals Has Exercised its Exclusive Option to Develop Therapeutic Candidates for Alzheimer’s Disease, Enabled by J-Brain Cargo® Technology Platform
Go back to JCR Pharmaceuticals Announces That Acumen Pharmaceuticals Has Exercised its Exclusive Option to Develop Therapeutic Candidates for Alzheimer’s Disease, Enabled by J-Brain Cargo® Technology Platform| Arbios Systems, Inc. (NASDAQ: ABOS) | Delayed: 3.16 -0.02 (0.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.18 | 52 Week High | $0.23 | |||
| Open | $3.14 | 52 Week Low | $0.00 | |||
| Day High | $3.29 | P/E | N/A | |||
| Day Low | $3.08 | EPS | $0.00 | |||
| Volume | 358,079 | |||||
